- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02305342
Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Family Physicians
Antibiotic Susceptibility of Bacterial Uro-Pathogens In Patients Attending Family Physicians" (In Vitro Study)
Study Overview
Status
Conditions
Detailed Description
Mid stream , clean catch urine specimens of patients with uncomplicated community acquired UTI sent to microbiology labs by treating consultants from filter clinics for evaluation of pathogens will be utilized for sensitivity analysis.
Only the first positive urine culture obtained per sample will be included in the analysis to eliminate any possibility of recurrence and nosocomial infection. The polymicrobial cultures and cultures with multidrug-resistant uropathogens will not be included in the analysis. Cultures with common contaminants, including coagulase-negative staphylococci and hemolytic streptococci, and cultures with Candida growth will be excluded. .
Data points to be collected will be date of collection, computer generated Lab #, age, gender,list of cultured organisms, sensitivity of organisms with antibiotics.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Karachi, Pakistan, 75190
- Research facility ID ORG-001126
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Samples from primary care clinics from patients who reports UTI symptoms and in which uropathogens are isolated will be included.
Exclusion Criteria:
- Samples from specialized, hospitalized or catheterized patients.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Urinary Tract Infections (UTIs)
Uncomplicated UTIs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sensitivity of Uropathogens
Time Frame: 3 months
|
Sensitivity of identified organisms shall be noted by the zone size in millimeters of the cultured organisms.
"Sensitive", "Intermediate" and "Resistant" labels shall be used as per Clinical Laboratory Standard Institute (CLSI) guidelines.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Common UTI pathogens
Time Frame: 3 months
|
To enlist the number and names of identified uropathogens from urine cultures.
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Raeefuddin Ahmed, MBBS, FCPS, Abbott
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ENOX5001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Tract Infections (UTIs)
-
HaEmek Medical Center, IsraelWithdrawnUrinary Tract Infections (UTIs)
-
Nationwide Children's HospitalThrasher Research FundCompletedCatheter-Related Infections | Recurrent UTIsUnited States
-
GlaxoSmithKlineCompletedInfections, Urinary TractEgypt
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Iterum Therapeutics, International LimitedCompletedComplicated Urinary Tract InfectionsUnited States, Estonia, Hungary, Georgia, Latvia
-
Shandong Branden Med.Device Co.,LtdTerminatedUrinary Tract Infection | Urinary CathetersChina
-
Inmunotek S.L.CompletedUrinary Tract Infection BacterialSpain, United Kingdom
-
Newcastle-upon-Tyne Hospitals NHS TrustCambridge University Hospitals NHS Foundation Trust; University of Southampton and other collaboratorsCompletedUrinary Tract Infections, RecurrentUnited Kingdom
-
Lawson Health Research InstituteCompletedUrinary Tract InfectionCanada
-
National Institute of Diabetes and Digestive and...Completed